MONDOGEN
MondoGen is a biotechnology company that focuses exclusively on the development of liver-specific gene therapy systems. Based on a version of the hepatitis B virus that is unable to cause disease, MondoGen's technology enables highly efficient transfer of genes into liver cells. MondoGen is applying its technology to develop therapeutics against viral, malignant and inherited liver disorders.
MONDOGEN
Industry:
Biotechnology Medical Therapeutics
Address:
Munich, Bayern, Germany
Country:
Germany
Status:
Active
Similar Organizations
Astex
Astex is a UK-based biotechnology company that discovers and develops novel small molecule therapeutics.
Centauri Therapeutics
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Neumedicines
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.